Versantis raises CHF16m in Series B financing
The CHF16m Series B financing was led by Swisscanto Invest by Zürcher Kantonalbank with co-financing by Esperante Venture, investiere, Redalpine...
Rotavirus vaccines kill cancer cells
The team headed by Aurelian Marabelle discovered in mice that commercially available vaccines against rotavirus – which causes diarrhea in children...
Pharvaris BV raises $66m to advance oral HAE drug
The Series B financing was led by Foresite Capital. New investors Bain Capital Life Sciences, venBio and Venrock, as well as the investors of a €15m...
ADC Therapeutics enters licence option deal with Avacta Group
Under the terms of the agreement, Avacta Group (Cambridge, UK) will provide three small Affimer proteins designed to bind to undisclosed cancer...
2nd ECP Summer Summit at Henkel HQ, Düsseldorf
On September 26, international representatives from startups, SMEs, large companies. clusters, industry parks and further services providers came...
Ermium Therapeutics bags €6.3m in Series A round
Domain Therapeutics, Kurma Partners, Idinvest, and the SATT Erganeo contributed to the financing. Ermium Therapeutics has licenced exclusively...
Protein protects against liver fibrosis
In mice, a team headed by Philipp Lang from University Düsseldorf, Germany, showed that the iRhom2 protein counteracted the injury- and...